Status:
COMPLETED
Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases
Lead Sponsor:
Universidade Nova de Lisboa
Collaborating Sponsors:
Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental
Department of Neurology, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental
Conditions:
Biomarker
Lipid
Eligibility:
All Genders
18+ years
Brief Summary
Collect blood from patients admitted for coronary angiography to tubes with heparin, centrifuge and collect plasma. This will be frozen at -80C. Sent to the Lipotype laboratory, Dresden, Germany, for ...
Detailed Description
Plasma samples were obtained from a total of 427 individuals. Baseline characteristics are outlined in Table 1. Control (n = 85) were taken from the population of the Coimbra and Lisbon, Portugal, reg...
Eligibility Criteria
Inclusion
- Patients admitted for coronary angiography due to suspected coronary disease (silent ischemia, stable angina and acute coronary syndromes)
Exclusion
- Patients unable to give informed consent
Key Trial Info
Start Date :
March 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
427 Patients enrolled
Trial Details
Trial ID
NCT04786431
Start Date
March 1 2015
End Date
March 1 2021
Last Update
March 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.